From 100669a886932c925810bf1375ae590594a4f98b Mon Sep 17 00:00:00 2001 From: m3taversal Date: Fri, 6 Mar 2026 13:06:41 +0000 Subject: [PATCH] vida: fix pipe-alias wiki link in Oura claim - What: Removed pipe alias syntax from wiki link to multi-layer sensor stack claim - Why: Pipe alias [[target|display]] may not resolve correctly in git-based knowledge base Pentagon-Agent: Vida Co-Authored-By: Claude Opus 4.6 --- ...to wellness-focused women drives 250 percent sales growth.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/domains/health/Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth.md b/domains/health/Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth.md index bf8b5ad..59e07ba 100644 --- a/domains/health/Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth.md +++ b/domains/health/Oura controls 80 percent of the smart ring market with patent-defended form factor while a demographic pivot from fitness enthusiasts to wellness-focused women drives 250 percent sales growth.md @@ -17,7 +17,7 @@ The retention data validates the pivot: 12-month retention in the high-80s, comp Oura is actively defending its position through patent litigation. In November 2025, it filed ITC complaints against Samsung (Galaxy Ring), Reebok, Amazfit, and Luna for form factor patent infringement. Samsung's attempt to invalidate Oura's core patent at PTAB failed. The strategic question is whether these patents create a durable moat or merely slow competitors. -Three acquisitions in two years signal platform ambitions beyond the ring: Proxy (identity/auth, 2023), Veri (CGM app, 2024), and Sparta Science (enterprise analytics, 2024). The Veri acquisition is especially significant -- it positions Oura to integrate continuous glucose monitoring into its ring data platform, moving toward the [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware|multi-layer sensor stack convergence]] already documented in the health landscape. +Three acquisitions in two years signal platform ambitions beyond the ring: Proxy (identity/auth, 2023), Veri (CGM app, 2024), and Sparta Science (enterprise analytics, 2024). The Veri acquisition is especially significant -- it positions Oura to integrate continuous glucose monitoring into its ring data platform, moving toward the [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] already documented in the health landscape. The key risk is valuation: $11B at ~22x revenue is aggressive. A tender offer at 25% discount suggests some secondary market participants see it as stretched. The Samsung patent battle outcome remains uncertain despite early wins. And the Palantir/DoD privacy controversy (August 2025), while factually overblown, demonstrated consumer sensitivity around biometric data governance. -- 2.45.2